ReviewFrontiers in oncology2025

The potential of antibody-drug conjugates in immunotherapy for non-small cell lung cancer: current progress and future.

Hongyu Lin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.